The company
Surgery Partners, Inc.
SGRY · Nasdaq
SGRY stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 2.9% above that average now. Providers & Facilities: 43% of its 53 stocks in an uptrend (−4 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 43% -4 in 4 wk
- Insider buys, 12 months
- $609K
- Insider sales, 12 months
- $2.6M
- Officials’ trades on record
- 0
- Institutions holding
- 176 (+8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Teresa DelucaDirector | bought | 10,000at $14.35 | 18 Aug 2026filed 19 Aug 2026 |
| Teresa DelucaDirector | bought | 11,250at $14.33 | 18 Aug 2026filed 20 Aug 2026 |
| Jason Eric EvansChief Executive Officer | sold | 20,400at $12.47 | 16 Mar 2026filed 16 Mar 2026 |
| David T. DohertyChief Financial Officer | sold | 8,867at $12.50 | 16 Mar 2026filed 16 Mar 2026 |
| Marissa BrittenhamChief Strategy Officer | sold | 3,657at $12.54 | 13 Mar 2026filed 16 Mar 2026 |
| Danielle BurkhalterChief Human Resources Officer | sold | 3,469at $12.83 | 13 Mar 2026filed 16 Mar 2026 |
| Jennifer BaldockChief Admin & Dev Officer | sold | 5,798at $13.17 | 12 Mar 2026filed 16 Mar 2026 |
| Marissa BrittenhamChief Strategy Officer | sold | 8,785at $13.70 | 6 Mar 2026filed 9 Mar 2026 |
| William Trenton WebbAmerican Group President | sold | 272at $13.93 | 6 Mar 2026filed 9 Mar 2026 |
| Danielle BurkhalterChief Human Resources Officer | sold | 7,736at $13.60 | 6 Mar 2026filed 9 Mar 2026 |
| Jennifer BaldockChief Admin & Dev Officer | sold | 10,082at $13.70 | 6 Mar 2026filed 9 Mar 2026 |
| David T. DohertyChief Financial Officer | sold | 14,574at $13.84 | 6 Mar 2026filed 9 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Investors LLCunchanged · filed 14 Aug 2026 | 49,946,972$839.1M | 00.0% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 13,882,155$233.2M | +13,882,155 |
| Pentwater Capital Management LPreduced · filed 14 Aug 2026 | 11,630,000$195.4M | -1,025,000−8.1% |
| UBS Group AGreduced · filed 13 Aug 2026 | 8,573,413$144.0M | -1,618,368−15.9% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 6,241,503$104.9M | +580,715+10.3% |
| KING STREET CAPITAL MANAGEMENT, L.P.reduced · filed 14 Aug 2026 | 6,058,141$101.8M | -4,171,589−40.8% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 4,943,713$83.1M | -352,698−6.7% |
| Clearbridge Investments, LLCreduced · filed 13 Aug 2026 | 3,823,179$64.2M | -294,877−7.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,737,712$62.8M | +109,281+3.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,509,535$59.0M | +78,740+2.3% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.